ISRCTN15313991进行中（未招募）3 期
Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acid
niversity of Edinburgh0 个研究点目标入组 350 人开始时间: 2016年8月10日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 350
研究概览
简要总结
2023 Protocol article in https://doi.org/10.1136/bmjopen-2023-078164 (added 23/11/2023)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Adult patients age 18 years and over with a clinical diagnosis of osteogenesis imperfecta
- •2. Patients willing and able to consent and comply with the study protocol
排除标准
- •Current exclusion criteria as of 07/02/2017:
- •1. Current or previous treatment with an investigational (non-licensed) drug with effects on bone metabolism
- •2. Contraindication to TPTD or ZA
- •3. Women of childbearing potential not using highly effective methods of contraception
- •4. Pregnancy
- •5. Women that are breastfeeding
- •6. Age < 18 years
- •Previous exclusion criteria:
- •1. Contraindication to TPTD or ZA
- •2. Current or previous treatment with an investigational drug with effects on bone metabolism
- •3. Women of childbearing potential not using adequate contraception
- •4. Pregnancy
研究者
相似试验
已完成
4 期
Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic AcidOsteogenesis ImperfectaNCT03735537University of Edinburgh350
进行中（未招募）
1 期
Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acidMedDRA version: 20.0Level: PTClassification code 10031243Term: Osteogenesis imperfectaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersOsteogenesis imperfectaEUCTR2016-003228-22-IEniversity of Edinburgh380
进行中（未招募）
1 期
Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acidMedDRA version: 20.0Level: PTClassification code 10031243Term: Osteogenesis imperfectaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersOsteogenesis imperfectaEUCTR2016-003228-22-GBniversity of Edinburgh380
尚未招募
4 期
Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acidOIbrittle bone disease100274241001329610005959NL-OMON55540ACCORD50
进行中（未招募）
1 期
Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acidOsteogenesis imperfectaEUCTR2016-003228-22-NLniversity of Edinburgh380